Merit Medical Systems announced commercial release of its US Food and Drug Administration-cleared Micro ACE Advanced Micro-Access System. Merit also intends to file Micro ACE for CE mark designation. The Micro ACE system is the latest innovation in the Merit Vascular portfolio. The comprehensive portfolio includes a full range of percutaneous access and closure devices. Combining a balance of stiffness and resiliency, Micro ACE is designed to achieve micro-access in a wide range of vascular anatomies.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MMSI:
- Merit Medical Launches the Micro ACE™ Advanced Micro-Access System
- Merit Medical Systems to Announce First Quarter 2024 Results on April 30, 2024
- Merit Medical to Host Evening of Innovation during the 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting
- Merit Medical price target raised to $85 from $81 at Wells Fargo
- Merit Medical price target raised to $98 from $96 at Barrington
